Umbilical Cord Blood-Derived Stem Cells and Exosomes therapy ( Adia Med of Winter Park)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameUmbilical Cord Blood-Derived Stem Cells and Exosomes therapy ( Adia Med of Winter Park)

Drug Alias NameAdiaVita

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapyBiologics > Exosomes > Stem cell-derived exosomes

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsAutistic DisorderAutism Spectrum DisorderLow Back Pain +[6]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAdia Med of Winter Park Llc

China Registration ClassN/A

Develop Information

Active CompaniesAdia Med of Winter Park Llc

Inactive CompaniesN/A

Active IndicationsAutistic DisorderAutism Spectrum DisorderLow Back Pain +[6]

Inactive IndicationsN/A

Other Information

ATC CodeN/A